🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
Treatment of higher-risk (intermediate, high and very high) Myelodysplastic...
Status
Completed
Location
AOU Careggi- University of Florence
Start Date
2021-03-24
Trial ID
NCT04806906
Treatments Being Tested
Observational, cross sectional study, carried out with the help of a pre-de...
Status
Completed
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02820220
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
The primary objective is to characterize the programming effects of Boston ...
Status
Completed
Location
CHU Grenoble - Hopital Michallon
Start Date
2016-07-19
Trial ID
NCT02835274
Treatments Being Tested
The purpose of this phase III study is to determine whether Doxorubicin Tra...
Status
Completed
Location
Gabrail Cancer Center
Start Date
2012-06
Trial ID
NCT01655693
Treatments Being Tested
This is a Phase 3, double-blind, randomized, placebo-controlled, multicente...
Status
Completed
Location
Children's Hospital of Los Angeles
Start Date
2016-05-02
Trial ID
NCT02604433
Treatments Being Tested
This Phase 2 study is to be conducted to evaluate the safety, tolerability,...
Status
Completed
Location
Pulmonary Associates, PA
Start Date
2016-05-26
Trial ID
NCT02688647
Treatments Being Tested
The objective of this Phase III study is to evaluate the efficacy of ninted...
Status
Completed
Location
1199.52.0108 Boehringer Ingelheim Investigational Site
Start Date
2014-09-25
Trial ID
NCT02149108
Treatments Being Tested